aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Stereotaxis Inc., founded in St. Louis, MO, is a publicly traded American medical robotics company focused on enhancing clinical outcomes in electrophysiology. The company's core mission is to advance interventional medicine through innovative robotic technologies. Their flagship product, the NIOBE® ES Remote Magnetic Navigation (RMN) System, allows for precise and minimally invasive procedures, targeting small areas within the body for ablation, biopsy, and other interventions. Stereotaxis primarily serves healthcare professionals and patients seeking advanced treatment options.
Notable figures associated with Stereotaxis include its leadership team and key investors who have supported its growth and technological advancements. The company has achieved significant milestones, including widespread adoption of its RMN system in leading medical institutions globally. Stereotaxis' impact is evident in improved patient outcomes and the advancement of minimally invasive surgical techniques, solidifying its position as a pioneer in the field of medical robotics.
Operating Status
Active
Ownership Type(s)
Public
Main Product(s)
Medical Robotics
Technology
Robotics
Tags
Healthtech
Model Types
Hardware, Medical
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
United States
When was Stereotaxis founded?
Stereotaxis was founded in 1990.
Where is Stereotaxis's headquarters located?
Stereotaxis's headquarters is located in St. Louis, MO, US.
When was Stereotaxis's last funding round?
Stereotaxis's most recent funding round was for $25M (USD) in August 2019.
How many employees does Stereotaxis have?
Stereotaxis has 130 employees as of Feb 6, 2024.
How much has Stereotaxis raised to-date?
As of July 05, 2023, Stereotaxis has raised a total of $105M (USD) since Aug 8, 2019.
Add Comparison
Total Raised to Date
$105M
USD
Last Update Aug 8, 2019
Last Deal Details
$25M
USD
Aug 8, 2019
Post Ipo Equity
Total Employees Over Time
130
As of Feb 2024
Stereotaxis Address
4041 Forest Park Av
St. Louis,
Missouri
63108
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts